End-of-day quote
Korea S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
24,200
KRW
|
-1.22%
|
|
+2.98%
|
+16.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
241,664
|
212,485
|
177,883
|
150,392
|
143,853
|
166,967
|
-
|
Enterprise Value (EV)
2 |
178.3
|
212.5
|
177.9
|
89.99
|
143.9
|
88.77
|
78.77
|
P/E ratio
|
-
|
-
|
7.87
x
|
8.45
x
|
6.29
x
|
7.44
x
|
6.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.35
x
|
3.68
x
|
-
|
1.68
x
|
1.52
x
|
1.52
x
|
1.35
x
|
EV / Revenue
|
2.47
x
|
3.68
x
|
-
|
1.01
x
|
1.52
x
|
0.81
x
|
0.64
x
|
EV / EBITDA
|
6,694,244,677
x
|
-
|
-
|
4,280,490,442
x
|
-
|
-
|
-
|
EV / FCF
|
7,803,352
x
|
-
|
-
|
5,236,905
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.76
x
|
-
|
-
|
0.83
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
7,139
|
7,154
|
7,130
|
6,947
|
6,899
|
6,899
|
-
|
Reference price
3 |
33,850
|
29,700
|
24,950
|
21,650
|
20,850
|
24,200
|
24,200
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
72.13
|
57.77
|
-
|
89.4
|
94.63
|
110.2
|
123.6
|
EBITDA
|
26.64
|
-
|
-
|
21.02
|
-
|
-
|
-
|
EBIT
1 |
24.57
|
10.64
|
-
|
17.86
|
16.66
|
20.4
|
24.7
|
Operating Margin
|
34.06%
|
18.41%
|
-
|
19.98%
|
17.61%
|
18.51%
|
19.98%
|
Earnings before Tax (EBT)
|
28.92
|
9.356
|
-
|
19.46
|
-
|
-
|
-
|
Net income
1 |
25.94
|
-
|
22.65
|
17.87
|
23.3
|
21.5
|
26.4
|
Net margin
|
35.97%
|
-
|
-
|
19.99%
|
24.62%
|
19.51%
|
21.36%
|
EPS
2 |
-
|
-
|
3,172
|
2,563
|
3,316
|
3,252
|
3,842
|
Free Cash Flow
|
22,852
|
-
|
-
|
17,185
|
-
|
-
|
-
|
FCF margin
|
31,681.44%
|
-
|
-
|
19,222.93%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
85,786.78%
|
-
|
-
|
81,737.02%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
88,088.4%
|
-
|
-
|
96,177.57%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
63.3
|
-
|
-
|
60.4
|
-
|
78.2
|
88.2
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
22,852
|
-
|
-
|
17,185
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
21.2%
|
6.56%
|
-
|
10.3%
|
12.1%
|
10.6%
|
11.2%
|
ROA (Net income/ Total Assets)
|
19.6%
|
-
|
-
|
9.67%
|
-
|
-
|
-
|
Assets
1 |
132.1
|
-
|
-
|
184.8
|
-
|
-
|
-
|
Book Value Per Share
|
19,190
|
-
|
-
|
26,171
|
-
|
-
|
-
|
Cash Flow per Share
|
3,769
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
0.61
|
-
|
-
|
1.68
|
-
|
-
|
-
|
Capex / Sales
|
0.85%
|
-
|
-
|
1.88%
|
-
|
-
|
-
|
Announcement Date
|
2/10/20
|
2/4/21
|
3/14/22
|
2/6/23
|
2/8/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +16.07% | 121M | | -23.60% | 1.59B | | +168.41% | 151M | | -31.21% | 48.04M |
Biometric Products
|